New! View global litigation for patent families

US4664913B1 - - Google Patents

Download PDF

Info

Publication number
US4664913B1
US4664913B1 US63275684A US4664913B1 US 4664913 B1 US4664913 B1 US 4664913B1 US 63275684 A US63275684 A US 63275684A US 4664913 B1 US4664913 B1 US 4664913B1
Authority
US
Grant status
Grant
Patent type
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Inventor
Harold Mielke C
J Scannon Patrick
R Sohmer Paul
C Klock John
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
XOMA Corp A DE CORP
XOMA Corp
Original Assignee
XOMA Corp 3516 SACRAMENTO ST SAN FRANCISCO CA 94118 A DE CORP
XOMA Corp A DE CORP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
US4664913B1 1982-05-24 1984-07-19 Expired - Lifetime US4664913B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US38149982 true 1982-05-24 1982-05-24
US4664913B1 US4664913B1 (en) 1982-05-24 1984-07-19

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4664913B1 US4664913B1 (en) 1982-05-24 1984-07-19
DE19873778002 DE3778002D1 (en) 1984-07-19 1987-01-27 Method for treatment of plasma and its products.
EP19870101072 EP0276342B1 (en) 1984-07-19 1987-01-27 Method for treating plasma and products thereof
ES87101072T ES2032276T3 (en) 1984-07-19 1987-01-27 Method for plasma treatment and products derived therefrom.

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US38149982 Continuation-In-Part 1982-05-24 1982-05-24

Publications (2)

Publication Number Publication Date
US4664913A US4664913A (en) 1987-05-12
US4664913B1 true US4664913B1 (en) 1990-01-30

Family

ID=24536816

Family Applications (1)

Application Number Title Priority Date Filing Date
US4664913B1 Expired - Lifetime US4664913B1 (en) 1982-05-24 1984-07-19

Country Status (4)

Country Link
US (1) US4664913B1 (en)
EP (1) EP0276342B1 (en)
DE (1) DE3778002D1 (en)
ES (1) ES2032276T3 (en)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061237A (en) * 1985-07-02 1991-10-29 Cytomed Medizintechnik Gmbh Method of purifying whole blood
US5122112A (en) * 1986-11-21 1992-06-16 Imre Corporation Antigen-specific removal of circulating immune complexes
US5132406A (en) * 1986-05-19 1992-07-21 The Green Cross Corporation Method of producing immunoglobulin preparations for intravenous injection
US5147289A (en) * 1990-03-29 1992-09-15 Therakos, Inc Non-specific immune system enhancement
US5541294A (en) * 1992-05-28 1996-07-30 New York Blood Center, Inc. Removal of antibodies from blood-derived compositions while retaining coagulation factors
EP0896824A1 (en) * 1997-08-05 1999-02-17 Octapharma Ag A universally applicable blood plasma
WO2001027623A2 (en) * 1999-10-08 2001-04-19 V.I. Technologies, Inc. Isoagglutinin-depleted blood compositions and methods of making same
US20020119147A1 (en) * 1999-11-20 2002-08-29 Cytologic, Llc Apparatus for enhancing immune responses in mammals
WO2002083157A1 (en) * 2001-04-18 2002-10-24 Jianchuan Ma Blood group-free human blood plasma and the preparation method thereof
US20020182195A1 (en) * 1997-08-05 2002-12-05 Octapharma Ag Universally applicable blood plasma
US20040208865A1 (en) * 2003-02-12 2004-10-21 Chauhan Anil K. Immune complexes
US20040219613A1 (en) * 2001-08-01 2004-11-04 Chauhan Anil K Immune complexes
US20050244371A1 (en) * 1998-05-22 2005-11-03 Biopheresis Technologies, Llc Method and system to remove cytokine inhibitor in patients
US20050265996A1 (en) * 2004-04-30 2005-12-01 Biopheresis Technologies, Inc. Method and system to remove soluble TNFR1, TNFR2, and IL2 in patients
US20070065514A1 (en) * 2005-09-22 2007-03-22 Howell Mark D Method for enhancing immune responses in mammals
US20080075690A1 (en) * 2006-09-22 2008-03-27 Mark Douglas Howell Method for enhancing immune responses in mammals
US20080234653A1 (en) * 2007-03-19 2008-09-25 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US20090107001A1 (en) * 2007-03-19 2009-04-30 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US20090113753A1 (en) * 2007-03-19 2009-05-07 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US20090223080A1 (en) * 2007-03-19 2009-09-10 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US20100285044A1 (en) * 1998-05-22 2010-11-11 Lentz M Rigdon Method and compositions for treatment of cancers
US20110104298A1 (en) * 2003-12-19 2011-05-05 Octapharma Ag Universally applicable virus inactivated blood plasma produced from portions of non-Caucasians plasma
WO2016177966A1 (en) 2015-05-06 2016-11-10 Elicityl Method for the purification of whole blood or a blood-derived product
WO2016177967A1 (en) 2015-05-06 2016-11-10 Elicityl Substrate for the purification of body fluids

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8865172B2 (en) 2000-05-08 2014-10-21 Advanced Extravascular Systems, Inc. Method for reducing the number of unwanted molecules in bodily fluids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533440A1 (en) * 1982-09-24 1984-03-30 Inst Nat Sante Rech Med Device for the elimination or the recovery of biologically active substances from the blood, the production thereof and its use

Cited By (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061237A (en) * 1985-07-02 1991-10-29 Cytomed Medizintechnik Gmbh Method of purifying whole blood
US5132406A (en) * 1986-05-19 1992-07-21 The Green Cross Corporation Method of producing immunoglobulin preparations for intravenous injection
US5122112A (en) * 1986-11-21 1992-06-16 Imre Corporation Antigen-specific removal of circulating immune complexes
US5147289A (en) * 1990-03-29 1992-09-15 Therakos, Inc Non-specific immune system enhancement
US5541294A (en) * 1992-05-28 1996-07-30 New York Blood Center, Inc. Removal of antibodies from blood-derived compositions while retaining coagulation factors
US20020182195A1 (en) * 1997-08-05 2002-12-05 Octapharma Ag Universally applicable blood plasma
WO1999007390A1 (en) * 1997-08-05 1999-02-18 Octapharma Ag A universally applicable blood plasma
EP0896824A1 (en) * 1997-08-05 1999-02-17 Octapharma Ag A universally applicable blood plasma
JP2001513507A (en) * 1997-08-05 2001-09-04 オクタファルマ アクチェン ゲゼルシャフト Generally applicable plasma
US20070014806A1 (en) * 1997-08-05 2007-01-18 Octapharma Ag Universally applicable blood plasma
US20110008459A1 (en) * 1997-08-05 2011-01-13 Octapharma Ag Universally applicable blood plasma
US20090092678A1 (en) * 1997-08-05 2009-04-09 Octapharma Ag Universally applicable blood plasma
US8133490B2 (en) 1998-05-22 2012-03-13 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitors in patients
US20100285044A1 (en) * 1998-05-22 2010-11-11 Lentz M Rigdon Method and compositions for treatment of cancers
US8197430B1 (en) 1998-05-22 2012-06-12 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitor in patients
US20050244371A1 (en) * 1998-05-22 2005-11-03 Biopheresis Technologies, Llc Method and system to remove cytokine inhibitor in patients
US20080145333A1 (en) * 1998-05-22 2008-06-19 Biopheresis Technologies, Inc. Method and system to remove soluble tnfr1, tnfr2, and il2 in patients
US20080057060A1 (en) * 1998-05-22 2008-03-06 Biopheresis Technologies, Llc Method and system to remove cytokine inhibitor in patients
US7854717B1 (en) 1998-05-22 2010-12-21 Biopheresis Technologies, Inc. Method and compositions for treatment of cancers
WO2001027623A2 (en) * 1999-10-08 2001-04-19 V.I. Technologies, Inc. Isoagglutinin-depleted blood compositions and methods of making same
WO2001027623A3 (en) * 1999-10-08 2002-01-17 Vi Technologies Inc Isoagglutinin-depleted blood compositions and methods of making same
US20110201986A1 (en) * 1999-11-20 2011-08-18 Cytologic, Inc. Method for enhancing immune responses in mammals
US20020119147A1 (en) * 1999-11-20 2002-08-29 Cytologic, Llc Apparatus for enhancing immune responses in mammals
WO2002083157A1 (en) * 2001-04-18 2002-10-24 Jianchuan Ma Blood group-free human blood plasma and the preparation method thereof
US7682793B2 (en) 2001-08-01 2010-03-23 Chauhan Anil K Immune complexes
US20040219613A1 (en) * 2001-08-01 2004-11-04 Chauhan Anil K Immune complexes
US20040208865A1 (en) * 2003-02-12 2004-10-21 Chauhan Anil K. Immune complexes
US20110104298A1 (en) * 2003-12-19 2011-05-05 Octapharma Ag Universally applicable virus inactivated blood plasma produced from portions of non-Caucasians plasma
US20050265996A1 (en) * 2004-04-30 2005-12-01 Biopheresis Technologies, Inc. Method and system to remove soluble TNFR1, TNFR2, and IL2 in patients
US20090227750A1 (en) * 2005-09-22 2009-09-10 Mark Douglas Howell Mehod for enhancing immune response in mammals
US8501918B2 (en) 2005-09-22 2013-08-06 Cytologic, Inc. Immobilized tumor necrosis factor-α muteins for enhancing immune response in mammals
US20070065514A1 (en) * 2005-09-22 2007-03-22 Howell Mark D Method for enhancing immune responses in mammals
US20080075690A1 (en) * 2006-09-22 2008-03-27 Mark Douglas Howell Method for enhancing immune responses in mammals
US20090113753A1 (en) * 2007-03-19 2009-05-07 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US20090107001A1 (en) * 2007-03-19 2009-04-30 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US20090223080A1 (en) * 2007-03-19 2009-09-10 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US20080234653A1 (en) * 2007-03-19 2008-09-25 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US8449520B2 (en) 2007-03-19 2013-05-28 HemCon Medical Technologies Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US20080234654A1 (en) * 2007-03-19 2008-09-25 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US20110144613A1 (en) * 2008-08-15 2011-06-16 Hemcon Medical Technologies, Inc. Apparatus and Methods for Making, Storing, and Administering Freeze-Dried Materials Such as Freeze-Dried Plasma
WO2010033169A1 (en) * 2008-09-16 2010-03-25 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
WO2016177967A1 (en) 2015-05-06 2016-11-10 Elicityl Substrate for the purification of body fluids
WO2016177966A1 (en) 2015-05-06 2016-11-10 Elicityl Method for the purification of whole blood or a blood-derived product

Also Published As

Publication number Publication date Type
ES2032276T3 (en) 1993-02-01 grant
EP0276342A1 (en) 1988-08-03 application
EP0276342B1 (en) 1992-04-01 grant
DE3778002D1 (en) 1992-05-07 grant
US4664913A (en) 1987-05-12 grant

Similar Documents

Publication Publication Date Title
DE3203574C2 (en)
DE3200128C2 (en)
DE3214375C2 (en)
DE3204518C2 (en)
DE3209871C2 (en)
DE3201715C2 (en)
DE3211882C2 (en)
DE3203732C2 (en)
DE3217154C2 (en)
DE3215482C2 (en)
DE3208584C2 (en)
DE3208132C2 (en)
DE3203134C2 (en)
DE3217168C2 (en)
DE3206057C2 (en)
DE3216643C2 (en)
DE3210821C2 (en)
DE3213204C2 (en)
DE3200283C2 (en)
DE3209216C2 (en)
DE3215459C2 (en)
DE3216182C2 (en)
DE3212464C2 (en)
DE3208799C2 (en)
DE3208231C2 (en)

Legal Events

Date Code Title Description
AS Assignment

Owner name: XOMA CORPORATION, 3516 SACRAMENTO ST., SAN FRANCIS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:MIELKE, C. HAROLD;SCANNON, PATRICK J.;SOHMER, PAUL R.;AND OTHERS;REEL/FRAME:004291/0158;SIGNING DATES FROM 19840330 TO 19840718

RR Request for reexamination filed

Effective date: 19890227

B1 Reexamination certificate first reexamination
FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

REMI Maintenance fee reminder mailed
FP Expired due to failure to pay maintenance fee

Effective date: 19990512

FPAY Fee payment

Year of fee payment: 12

SULP Surcharge for late payment
PRDP Patent reinstated due to the acceptance of a late maintenance fee

Effective date: 20020429